Today’s note includes earnings updates on 12 companies, the podcast and the Catalyst Report. We publish the Catalyst Report on the Friday after each monthly issue of the Cabot Turnaround Letter. There were no changes to any of our ratings this week.
Read More
Reliable dividend stocks may seem obvious and boring. But if you buy them and hang on to them, they can make your future. Here are five that stand out now.
Read More
In this week's video, Mike Cintolo talks about how he's still advising clients to go slow and pick their spots, but he's also seeing more and more to like among growth stocks.
Read More
The market has had another choppy week, with some big ups and downs, both among the major indexes and individual stocks. As opposed to recent weeks, the big-cap indexes are down after this morning’s open, while some of the broader indexes are up or...
Read More
These growth investing rules have been carefully selected as the most important guidelines a growth investor can use in a successful investment program.
Read More
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Can Growth Break Free From the Chop?
In our opinion, there are three main things about the market that make it difficult for most investors to succeed. The first is its contrary nature—oftentimes, many of the same qualities that help you succeed in the world...
Read More
The U.S. economy is growing more quickly than before the pandemic, both the S&P 500 and S&P 600 are up modestly over the past week and, so far, this earnings season has been a massive improvement over the train wreck of the first-quarter season...
Read More
Chinese stocks were hit this week both on American exchanges and overseas as Chinese regulators ratcheted up the pressure through antitrust and regulatory steps that caught many executives and investors off guard. The Golden Dragon index of Chinese technology stocks fell by 15% two...
Read More
The rise of financial technology has been a positive theme of late. With that in mind, these five fintech ETFs are worth your consideration.
Read More
The Dividend Aristocrats ETF might be one of the surest bets in the stock market. But there's a dark side to this shining star.
Read More
A crazy earnings season meets a sideways market. Investors have been looking for a narrative that gains traction. Maybe earnings will provide it.
Read More
If you know how to find small-cap stocks, you can consistently unlock better-than-average market returns. These five steps will help you find the right small caps.
Read More
Waiting for the Uptrend
The father of value investing, Benjamin Graham, once noted that in the long run, the stock market functions like a weighing machine, assessing the substance of a company and reflecting its true value over time, but in the short run, resembles...
Read More
The stock market reached yet another record high on Monday, but it just doesn’t seem the same as earlier records. Investors (and everyone else) is starting to wonder if Covid is now endemic – an inherent component of everyday life. Will cases surge the...
Read More
Investing in micro-caps is fun because you can invest in growth companies at value prices. When investing in pure “value” stocks, your goal is to buy a dollar for 50 cents. The problem is that the dollar of value can shrink over time 80...
Read More
It’s been a remarkably strong market, not just since the bottom of the pandemic-driven sell-off a little more than a year ago, but over the past decade.
Read More
The sideways market finally got some action. It went the wrong way. But it showed signs of life nonetheless.
Read More
Repligen (RGEN) reported Q2 results before the bell today that surpassed expectations and has the stock up nicely (6% at mid-day) and bucking the broader market weakness. Revenue was up 86% to $163 million, beating by nearly $19 million, while adjusted EPS of $0.79 by...
Read More
Call Financial Freedom Federation Customer Service at
(800) 777-2658
